Accu-Chek Guide and Accu-Chek Performa blood glucose meters 14 November 2019 Product defect correction – risk of delayed therapy due to potential battery issues Consumers and healthcare professionals are advised that Roche Diabetes Care Australia, in consultation with the Therapeutic Goods Administration (TGA), is undertaking a product defect correction for Accu-Chek Guide and Accu-Chek Performa blood glucose meters. Accu-Chek Guide and Accu-Chek Performa blood glucose meters are used by people with diabetes to monitor their blood glucose (also known as blood sugar) levels. These meters are supplied individually and also in a meter kit. Please visit www.accu-chek.com.au for more information. The TGA Safety Advisory can be found at: https://www.tga.gov.au/alert/accu-chek-guide-and-accu-chek-performa-blood-glucose-meters
Media releases 13 May 2026 Momentum builds following government response to diabetes inquiry The diabetes sector has welcomed the Federal Government’s response to the Parliamentary Inquiry into Diabetes, which provides in-principle support for... Continue Reading
Media releases 9 May 2026 Research reveals genes may determine who benefits most from popular weight-loss and diabetes medicines New research supported by Diabetes Australia has confirmed that a person’s genes can influence how well widely used diabetes medicines... Continue Reading
Blog 3 May 2026 Diabetes and Alzheimer’s: separating fact from fiction While research shows that type 2 diabetes is associated with a higher risk of Alzheimer's, many people with diabetes never develop dementia, and Alzheimer’s disease also affects people without diabetes. Continue Reading
